ARTICLE | Financial News
Danish Forward Pharma files for IPO
August 12, 2014 1:21 AM UTC
Forward Pharma A/S (Copenhagen, Denmark) filed to raise up to $200 million in an IPO on NASDAQ underwritten by Leerink Partners. The company expects to trade under the symbol "FWP."
Forward Pharma's lead product is FP187, an oral controlled-release small molecule dimethyl fumarate. The company submitted an IND to FDA for FP187 to treat relapsing-remitting multiple sclerosis (RRMS) and plans to submit the Phase III protocol this quarter. It will begin Phase III trials to treat moderate to severe plaque psoriasis in 2015. ...